 |
 |

Topiramate as Treatment for Alcohol Dependence
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In the clinical trial by Dr Johnson and colleagues,1 topiramate reduced the percentage of heavy drinking days in selected alcohol-dependent individuals. However, there was an important exclusion criterion that was not addressed in the discussion.
The study methods note that participants were excluded who "had a current Axis I psychiatric diagnosis on the DSM-IV other than alcohol, nicotine, or caffeine dependence," so that patients with current Axis I mood or anxiety disorders were not included in this trial. This may represent a large percentage of persons with alcohol dependence. In a community-based national survey of 43 093 respondents representative of a noninstitutionalized population (the National Epidemiologic Survey on Alcohol and Related Conditions), the 12-month prevalence of any mood disorder among persons with alcohol dependence was 28%, and the prevalence of any anxiety disorder was 23%.2 Among those with any alcohol use disorder who sought treatment in the past . . . [Full Text of this Article]
Olivier Ameisen, MD
oameisen@hotmail.com Paris, France
RELATED LETTERS
Topiramate as Treatment for Alcohol Dependence
George L. Spaeth and Anand V. Mantravadi
JAMA. 2008;299(4):405.
EXTRACT
| FULL TEXT
Topiramate as Treatment for Alcohol Dependence
Sarah Stringer, Marie Rueve, and Douglas Mossman
JAMA. 2008;299(4):405-406.
EXTRACT
| FULL TEXT
Topiramate as Treatment for Alcohol Dependence—Reply
Bankole A. Johnson, Nassima Ait-Daoud, Raymond F. Anton, Domenic A. Ciraulo, Henry R. Kranzler, Karl Mann, Stephanie S. OMalley, and Robert M. Swift
JAMA. 2008;299(4):406-407.
EXTRACT
| FULL TEXT
Topiramate as Treatment for Alcohol Dependence—Reply
Mark L. Willenbring
JAMA. 2008;299(4):407.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Topiramate for Treating Alcohol Dependence: A Randomized Controlled Trial
Bankole A. Johnson, Norman Rosenthal, Julie A. Capece, Frank Wiegand, Lian Mao, Karen Beyers, Amy McKay, Nassima Ait-Daoud, Raymond F. Anton, Domenic A. Ciraulo, Henry R. Kranzler, Karl Mann, Stephanie S. OMalley, Robert M. Swift, and for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group
JAMA. 2007;298(14):1641-1651.
ABSTRACT
| FULL TEXT
|